coronary blood flow and myocardial energetics were assessed after the administration of a parenteral inotrope ( dobutamine hydrochloride ) and an oral vasodilator agent ( hydralazine ) in 10 patients with nonischemic congestive heart failure .
C0020223
hydralazine
C0018802
congestive heart